Well, sort of. According to reports, KaloBios Pharmaceuticals has reportedly filed for Chapter 11 bankruptcy listing more than $1.9m in debt and more than $8.1m in assets. Trouble for the company is mounting, considering, Nasdaq informed the company that because of Shrkeli’s deceit on the stock market — they would be delisted come 25 December.
Reading Time: < 1 minuteDonate
Troubling developments in the case for Brett Kavanaugh’s Supreme Court nomination. In an open letter posted to Medium.com, some…Reading Time: < 1 minuteDonate
It’s Monday morning, and, the Queen of chillin abruptly on Instagram is back. One of the hottest tracks of…
Reading Time: < 1 minuteDonate
In a first-time extensive sit down, Lamar Odom, has come out swinging on allegations against his reputation and that…